The company posted a consolidated net profit of Rs 54.3 crore in the third quarter of the current financial year (Q3FY25)
Marking a healthy improvement in its performance, DOMS, a stationery and art product company, has registered a 39.8 per cent in the third quarter of the current financial year. The company posted a consolidated net profit of Rs 54.3 crore in Q3FY25, compared to Rs 38.8 crore in Q3FY24.
The consolidated financial results of the company revealed a 34.9 per cent rise in revenue from operations which rose to Rs 501.1 crore in the recently concluded quarter. The company’s revenue from operations was Rs 371.6 crore in the corresponding period of the previous fiscal.
“Despite the tepid market conditions and festive season in India as well as globally, we continued on our consistent growth trajectory during Q3FY25. Our strategic initiatives have played a pivotal role in fuelling this growth. The successful acquisition of Uniclan Healthcare, which lead our entry into Baby Hygiene products, coupled with our timely expansion of capacities across various product categories, have all contributed positively to our quarterly performance,” stated Santosh Raveshia, Managing Director, DOMS Industries.
The earnings before interest, tax, depreciation and amortisation (EBITDA) for the third quarter of the current fiscal grew by 26.7 per cent on a YoY basis to Rs 87.9 crore as compared to Rs 69.3 crore in Q3FY24. EBITDA margin for the recently concluded quarter stood at 17.5 per cent as compared to 18.7 per cent in Q3FY24.
“Going forward, we remain cautiously optimistic in the near term, on improvement in demand conditions with tailwinds from the upcoming back to school season, growing emphasis on education and increased Governments’ spending in this sector, contributing to the growth momentum,” stated the company. It witnessed an increase in selling and distribution expenses primarily on account of consolidation of Uniclan Healthcare.
